FDA Approves Updated COVID Vaccines, but Fewer People Will Be Eligible
People 65 or older or with an underlying health condition will likely still be eligible for the new vaccine
Prenatal Exposure to Acetaminophen May Affect Infant’s Brain
Twenty-seven of 46 studies reported positive associations between acetaminophen use and neurodevelopmental disorders in offspring
Treatment Response to Antiseizure Medications Can Take More Than One Year
Most participants with newly diagnosed focal episodes achieve seizure freedom; 27 percent become seizure-free with first ASM
New GLP-1 Pill Helps People Lose 23 Pounds in Study
The pill offers an alternative to injections, which some people find difficult or unpleasant.
GLP-1 Receptor Agonist Use Linked to Reduced Overall Risk for Cancer in Adults With...
Significantly lower risks seen for endometrial cancer, ovarian cancer, meningioma; nonsignificantly increased risk seen for kidney cancer
U.S. Justice Department Subpoenas Health Records of Young Transgender Patients
29 Percent of Infants Immunized Against RSV in 2023 to 2024 Season
Infant RSV immunization coverage through nirsevimab or maternal vaccination ranged from an estimated 11 to 53 percent by state
FDA Suspends U.S. License of Chikungunya Vaccine
Ixchiq has been linked to more than 20 serious adverse events resembling chikungunya illness
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
Papzimeos is the first and only FDA-approved therapy for the treatment of adults with recurrent respiratory papillomatosis
Weather Disasters Impacted Counties With More Than 60 Percent of Drug Production Facilities
All types of climate-related disasters were declared in at least one county with an active drug production facility, with hurricanes most common
